Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 8, 2007, Pages 1094-1096

  Roche, S ^a   Cassidy, F ^a   Zhao, C ^b   Badger, J ^b   Claffey, E ^c   Mooney, L ^c   Delaney, C ^c   Dobrin, S ^d   McKeon, P ^a,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b MARSHFIELD CLINIC   (United States)

^c ST PATRICK S HOSPITAL   (Ireland)

^d MONSANTO COMPANY   (United States)

Author keywords

Association; Disease variant; Haplotype; Linkage; Schizophrenia; Single nucleotide polymorphisms (SNPs); TRPM2

Indexed keywords

CLUSTERIN; NEUROTROPHIC FACTOR; PROTEIN S100B; TRANSCRIPTION FACTOR;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME 21Q; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; CHROMOSOMES, HUMAN, PAIR 21; DNA; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS;

EID: 36749009604     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30556     Document Type: Article

References (17)

1. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler TJ, Rudolf S, et al. 2003. S100B and response to treatment in major depression: A pilot study. Eur Neuropsychopharmacol 13(4):235-239.
2. Cassidy F, Zhao C, Badger J, Claffey E, Dobrin S, Roche S, et al. 2007. A bipolar disorder whole genome linkage scan and an investigation of population stratification effects: Support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24 and 16p13. Am J Med Genet B Neuropsychiatr Genet In press.
3. Gerlai R, Roder J. 1995. Abnormal exploratory behaviour in transgenic mice carrying multiple copies of the human gene for S100 beta. J Psychiatry Neurosci 20(2):105-112.
4. Himeda CL, Ranish JA, Angello JC, Maire P, Aebersold R, Hauschka SD. 2004 Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer. Mol Cell Biol 24(5):2132-2143.
5. Kawakami K, Sato S, Ozaki H, Ikeda K. 2000. Six family genes - Structure and function as transcription factors and their roles in development. Bioessays 22(7):616-626.
6. Liu J, Shi Y, Tang J, Guo T, Li X, Yang Y, et al. 2005. SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem Biophys Res Commun 328(1):335-341.
7. Machado-Vieira R, Lara DR, Portela LV, Goncalves CA, Soares JC, Kapczinski F, et al. 2002. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol 12(3):269-272.
8. Machado-Vieira R, Schmidt AP, Avila TT, Kapczinski F, Soares JC, Souza DO, et al. 2004. Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain. Life Sci 76(7):805-811.
9. Manev R, Uz T, Manev H. 2001. Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus. Eur J Pharmacol 420(2-3):R1-2.
10. McQuillin A, Bass NJ, Kalsi G, Lawrence J, Puri V, Choudhury K, et al. 2006. Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3. Mol Psychiatry 11(2):134-142.
11. Nishiyama H, Knopfel T, Endo S, Itohara S. 2002. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad Sci U S A 99(6):4037-4042.
12. Ohto H, Takizawa T, Saito T, Kobayashi M, Ikeda K, Kawakami K. 1998. Tissue and developmental distribution of Six family gene products. Int J Dev Biol 42(2):141-148.
13. Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, et al. 2001. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 6(4):445-449.
14. Rothermundt M, Peters M, Prehn JH, Arolt V. 2003. S100B in brain damage and neurodegeneration. Microsc Res Tech 60(6):614-632.
15. Rothermundt M, Falkai P, Ponath G, Abel S, Burkle H, Diedrich M, et al. 2004. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9(10):897-899.
16. Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE. 2002. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport 13(13):1675-1678.
17. Xu C, Macciardi F, Li PP, Yoon IS, Cooke RG, Hughes B, et al. 2006. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 141(1):36-43.